Alpha Layer / Signal Explorer

Signal Explorer

10-K · 10-Q · 8-K · last 6 months · ← back to feed

Clear ×
HCW Biologics Inc. HCWB

Showing 10-K, 10-Q & 8-K from the last 6 months. Need full history or all form types?

Apr 16, 2026 8-K 3 signals fired
Other
Quorum Adjournment Provision Equity Plan Board Approval Conditional On Shareholder Vote Adjournment Proposal Voting Requirement
Mar 17, 2026 8-K 4 signals fired
Core
Lead Asset Progress Indication Expansion
Other
Inlicensing Deal Completed Kol Endorsement
Mar 2, 2026 8-K 12 signals fired
Other
Nasdaq Minimum Bid Price Delisting Notice Safety Differentiated Interim Data Positive Enrollment Ahead Of Schedule Priority Review Or Pdufa Disclosed Checkpoint Inhibitor Program
Core
Lead Asset Progress Clinical Trial Result Combination Therapy Mentioned Clinical Hold Indication Expansion
Biotech Risk
Clinical Hold Active
Feb 19, 2026 8-K 10 signals fired
Other
Ipo Net Proceeds Disclosure Corporate Authority Representation Market Price Definition Closing Deliverables Specified Form S3 Shelf Registration Disclosure Use Of Proceeds Disclosure Warrant Exercise Share Delivery Institutional Investment Ipo Or Capital Raising Completion
Core
Lead Asset Progress
Feb 13, 2026 8-K 10 signals fired
Core
Indication Expansion Lead Asset Progress Clinical Trial Result
Other
Safety Differentiated Interim Data Positive Kol Endorsement Mrna Drug Platform Inlicensing Deal Completed Enrollment Ahead Of Schedule
Biotech v3
Ind Submission Planned
Dec 31, 2025 8-K 2 signals fired
Other
Nasdaq Minimum Bid Price Delisting Notice Warrant Valued Black Scholes
Nov 20, 2025 8-K 12 signals fired
Other
Market Price Definition Corporate Authority Representation Institutional Investment Ipo Net Proceeds Disclosure Form S3 Shelf Registration Disclosure Exchange Offer Letter Of Transmittal Registration Rights Piggyback Provision Warrant Exercise Share Delivery Warrant Valued Black Scholes Survival Of Representations Warranties Clause Closing Logistics Specified Warrant Redemption Cashless Exercise Provision
Nov 19, 2025 8-K 1 signal fired
Other
Inlicensing Deal Completed
Nov 18, 2025 8-K 17 signals fired · top 15
Core
Clinical Trial Result Lead Asset Progress Indication Expansion Regulatory Designation Only Secondary Endpoint Mentioned Combination Therapy Mentioned Clinical Hold
Other
Interim Data Positive Enrollment Ahead Of Schedule Kol Endorsement Patient Retention High Safety Differentiated Protocol Amended First Patient Treated Fast Track Granted
Nov 14, 2025 10-Q 52 signals fired · top 15
Other
Net Loss Reported Cash Flow Statement Investing Activities Nasdaq Minimum Bid Price Delisting Notice Quarterly Dividend Declared Codm Segment Reporting Disclosure Financing Activities Cash Flow Disclosure Safety Differentiated Warrant Redemption Cashless Exercise Provision Segment Aggregation Disclosure Covenant Compliance Affirmation Interim Data Positive Other Income Expense Disclosure Car T Cell Therapy
Core
Clinical Trial Result Lead Asset Progress
Nov 14, 2025 8-K 14 signals fired
Other
Net Loss Reported Nasdaq Minimum Bid Price Delisting Notice Interim Data Positive Enrollment Ahead Of Schedule Safety Differentiated Protocol Amended Kol Endorsement Ipo Or Capital Raising Completion
Core
Indication Expansion Lead Asset Progress Clinical Trial Result Clinical Hold Combination Therapy Mentioned
Biotech v3
Ind Submission Planned